Question 1

How many shares of WST does Capital Research Global Investors own?

Accepted Answer

As of 2026-Q2, Capital Research Global Investors holds 609,221 shares of WST (WEST PHARMACEUTICAL SERVICES).

Question 2

What is Capital Research Global Investors's WST position worth?

Accepted Answer

As of 2026-Q2, Capital Research Global Investors's WST position is worth $218.7M.

Question 3

Is Capital Research Global Investors buying or selling WST?

Accepted Answer

In 2026-Q2, Capital Research Global Investors increased their WST position (+0.9% change in shares).

Question 4

When did Capital Research Global Investors first buy WST?

Accepted Answer

Based on available 13F filings, Capital Research Global Investors first reported a position in WST in 2024-Q3. They have held the position across 23 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	609,221	+0.9%	$218.7M	0.0%	$358.77	31
2026-Q1	New	604,011	—	$151.4M	0.0%	$250.29	42
2025-Q2	Exited	0	-100.0%	$0	0.0%	$217.94	0
2025-Q1	Increased	390,678	+75.0%	$87.5M	0.0%	$222.78	45
2024-Q4	Increased	223,210	+39.3%	$73.1M	0.0%	$325.74	39
2024-Q3	New	160,193	—	$48.1M	0.0%	$298.30	40